Search results
Results from the WOW.Com Content Network
FDA Building 51 is one of the main buildings in its White Oak campus that houses the Center for Drug Evaluation and Research. The Center for Drug Evaluation and Research (CDER, pronounced "see'-der") is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act.
In 2002, the FDA transferred a number of biologically produced therapeutics to CDER. [8] CBER regulates a number of biologics-related products, including blood tests, computer software, and devices related to blood transfusion, which industry representatives would like to see handled by the much brisker Center for Devices and Radiological Health.
Assumed office April 12, 2021 Acting: May 2020 – April 2021: Preceded by: Janet Woodcock: Acting Principal Deputy Commissioner of Food and Drugs [2]; In office January 2019 – February 2019
The FDA Adverse Event Reporting System (FAERS or AERS) is a computerized information database designed to support the U.S. Food and Drug Administration's (FDA) postmarketing safety surveillance program for all approved drug and therapeutic biologic products.
Phone support is available for account management and password reset help, Mon-Fri: 8am-12am ET; Sat: 8am-10pm ET. For additional hours of operation for different services visit our support options page for contact info.
Create distribution lists to save time when you send emails to a group of contacts from the contacts you already have in your AOL Contacts, set up a contact list with a group of people you often send emails. For example, you email the same content to 3 friends every week. Instead, create a contact list called "Friends".
Save yourself time when sending the same email to multiple people by creating a group of your contacts. Instead of adding each email address separately, you can email a bunch of contacts by typing your group's name in the "To" field of a new email. Once you've created a group, you can continue to add, edit, or delete contacts from it. Add a group
A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows: . The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2).